Search - tctmd.com

Displaying 1 - 20 of 80

Sort: Relevancy | Date

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Presentation TCT 2024

TCT 1523: Cardiogenic Shock in the Setting AMI With VF/VT Arrest Necessitating Escalating MCS

Presenter: Andrew Corrigan

October 30, 2024

Presentation TCT 2024

Debate Pro: Keep P8 Impella 5.5 (de-escalate VA) as Bridge to Recovery

Presenter: Amirali Masoumi

October 29, 2024

Presentation TCT 2024

New Measures of Flow: Continuous and Bolus Thermodilution

Presenter: Javier Escaned

October 28, 2024

Presentation TCT 2024

TCT 415: Randomized Comparison of a Gladius First Versus Standard Guidewire Escalation Antegrade Wiring for Crossing Coronary Chronic Total Occlusions: The Gladius First Trial

Presenter: Maksymilian Opolski

October 28, 2024

Presentation TCT 2024

Unexpected Hemodynamic Collapse: Rapid Evaluation and Escalation Strategies

Presenter: Neal Kleiman

October 28, 2024

Presentation TCT 2024

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

Presenter: Donna Lin

October 27, 2024

Presentation TCT 2023

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

Presenter: Hyunki LEE

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

How to Make Wire Escalation More Efficient (Antegrade and Retrograde Cases)

Presenter: Rhian Davies

October 24, 2023

Presentation TCT 2023

Long Term Maintenance Antiplatelet Therapy After PCI

Presenter: Hyo-Soo Kim

October 24, 2023

Presentation TCT 2023

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

Presenter: Jacqueline Tamis-Holland

October 24, 2023

Presentation TCT 2023

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Presenter: Sripal Bangalore

October 24, 2023

Presentation TCT 2023

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Presenter: Harold Dauerman

October 24, 2023

Presentation TCT 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presenter: Dominick Angiolillo

October 24, 2023

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Short DAPT or De-Escalation After ACS

Presenter: Claudio Laudani

September 18, 2022

Presentation TCT 2022

TCT 816: Acute recoil following transcatheter aortic valve replacement with a self-expanding prosthesis in bicuspid aortic valve.

Presenter: Artemio Garcia-Escobar

September 17, 2022

Presentation TCT 2022

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

Presenter: Donggyu Moon

September 17, 2022

Presentation TCT 2022

TCT 17: Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study

Presenter: Niels van der Sangen

September 17, 2022

Advertisement

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

TCT 1523: Cardiogenic Shock in the Setting AMI With VF/VT Arrest Necessitating Escalating MCS

Debate Pro: Keep P8 Impella 5.5 (de-escalate VA) as Bridge to Recovery

New Measures of Flow: Continuous and Bolus Thermodilution

TCT 415: Randomized Comparison of a Gladius First Versus Standard Guidewire Escalation Antegrade Wiring for Crossing Coronary Chronic Total Occlusions: The Gladius First Trial

Unexpected Hemodynamic Collapse: Rapid Evaluation and Escalation Strategies

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

How to Make Wire Escalation More Efficient (Antegrade and Retrograde Cases)

Long Term Maintenance Antiplatelet Therapy After PCI

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Short DAPT or De-Escalation After ACS

TCT 816: Acute recoil following transcatheter aortic valve replacement with a self-expanding prosthesis in bicuspid aortic valve.

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

TCT 17: Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content